1. Home
  2. AEYE vs GOSS Comparison

AEYE vs GOSS Comparison

Compare AEYE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEYE
  • GOSS
  • Stock Information
  • Founded
  • AEYE 2005
  • GOSS 2015
  • Country
  • AEYE United States
  • GOSS United States
  • Employees
  • AEYE N/A
  • GOSS N/A
  • Industry
  • AEYE Computer Software: Prepackaged Software
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEYE Technology
  • GOSS Health Care
  • Exchange
  • AEYE Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • AEYE 205.3M
  • GOSS 237.9M
  • IPO Year
  • AEYE N/A
  • GOSS 2019
  • Fundamental
  • Price
  • AEYE $17.22
  • GOSS $0.96
  • Analyst Decision
  • AEYE Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • AEYE 5
  • GOSS 5
  • Target Price
  • AEYE $29.10
  • GOSS $9.20
  • AVG Volume (30 Days)
  • AEYE 253.3K
  • GOSS 1.0M
  • Earning Date
  • AEYE 03-05-2025
  • GOSS 03-04-2025
  • Dividend Yield
  • AEYE N/A
  • GOSS N/A
  • EPS Growth
  • AEYE N/A
  • GOSS N/A
  • EPS
  • AEYE N/A
  • GOSS N/A
  • Revenue
  • AEYE $33,348,000.00
  • GOSS $105,322,000.00
  • Revenue This Year
  • AEYE $14.66
  • GOSS N/A
  • Revenue Next Year
  • AEYE $21.01
  • GOSS N/A
  • P/E Ratio
  • AEYE N/A
  • GOSS N/A
  • Revenue Growth
  • AEYE 6.94
  • GOSS N/A
  • 52 Week Low
  • AEYE $4.52
  • GOSS $0.50
  • 52 Week High
  • AEYE $34.85
  • GOSS $1.60
  • Technical
  • Relative Strength Index (RSI)
  • AEYE 49.44
  • GOSS 54.23
  • Support Level
  • AEYE $13.61
  • GOSS $0.83
  • Resistance Level
  • AEYE $16.48
  • GOSS $1.18
  • Average True Range (ATR)
  • AEYE 1.12
  • GOSS 0.10
  • MACD
  • AEYE 0.46
  • GOSS -0.01
  • Stochastic Oscillator
  • AEYE 94.26
  • GOSS 41.37

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: